Powered by: Motilal Oswal

News

Marksans Pharma trades higher on getting USFDA`s final approval for Loratadine Tablets Marksans Pharma is currently trading at Rs. 313.90, up by 5.35 points or 1.73% from its previous closing of Rs. 308.55 on the BSE. The scrip opened at Rs. 318.00 and has touched a high and low of Rs. 318.70 and Rs. 310.00 respectively. So far 51508 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 328.35 on 20-Sep-2024 and a 52 week low of Rs. 126.05 on 14-Mar-2024. Last one week high and low of the scrip stood at...
Marksans Pharma trades higher on getting USFDA`s final approval for Loratadine Tablets
Marksans Pharma trades higher on getting USFDA`s final approval for Loratadine Tablets
Source: Accord Fintech
2024-11-25 12:38:19 pm
Marksans Pharma soars after its arm secures marketing authorization for three products Marksans Pharma is currently trading at Rs. 223.30, up by 2.40 points or 1.09% from its previous closing of Rs. 220.90 on the BSE. The scrip opened at Rs. 220.05 and has touched a high and low of Rs. 224.95 and Rs. 218.45 respectively. So far 180885 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 224.95 on 21-Aug-2024 and a 52 week low of Rs. 93.85 on 18-Sep-2023. Last one week high and low of the scrip stood at...
Marksans Pharma soars after its arm secures marketing authorization for three products
Marksans Pharma soars after its arm secures marketing authorization for three products
Source: Accord Fintech
2024-08-21 12:32:55 pm
Marksans Pharma rises after its arm gets Marketing Authorization for Levonorgestrel Tablets from UK MHRA Marksans Pharma is currently trading at Rs. 205.75, up by 0.30 points or 0.15% from its previous closing of Rs. 205.45 on the BSE. The scrip opened at Rs. 204.00 and has touched a high and low of Rs. 211.55 and Rs. 199.95 respectively. So far 74437 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 216.75 on 01-Aug-2024 and a 52 week low of Rs. 93.85 on 18-Sep-2023. Last one week high and low of the scrip stood at ...
Marksans Pharma rises after its arm gets Marketing Authorization for Levonorgestrel Tablets from UK MHRA
Marksans Pharma rises after its arm gets Marketing Authorization for Levonorgestrel Tablets from UK MHRA
Source: Accord Fintech
2024-08-02 01:53:18 pm
Marksans Pharma rises after its arm gets marketing authorization for four products Marksans Pharma is currently trading at Rs. 167.25, up by 0.65 points or 0.39% from its previous closing of Rs. 166.60 on the BSE. The scrip opened at Rs. 168.60 and has touched a high and low of Rs. 168.60 and Rs. 164.75 respectively. So far 81139 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 185.40 on 18-Apr-2024 and a 52 week low of Rs. 90.85 on 10-Jul-2023. Last one week high and low of the scrip stood at ...
Marksans Pharma rises after its arm gets marketing authorization for four products
Marksans Pharma rises after its arm gets marketing authorization for four products
Source: Accord Fintech
2024-07-03 12:36:41 pm
OUTPERFORM Marksans Pharma Ltd. For Target Rs.215 - Choice Broking Marksans Pharma specializes in the R&D, manufacturing, and marketing of generic pharmaceuticals, offering a comprehensive portfolio of over 300 products including tablets, capsules, oral liquids, and ointments across various therapeutic areas like pain management, cardiovascular health, anti-infectives, CNS disorders, anti-inflammatory conditions, and gastrointestinal ailments. Serving both over-the-counter (OTC) and prescription (Rx) markets, Marksans operates globally in over 50 countri...
OUTPERFORM Marksans Pharma Ltd. For Target Rs.215 - Choice Broking
OUTPERFORM Marksans Pharma Ltd. For Target Rs.215 - Choice Broking
Source: Choice Broking
2024-06-27 03:53:28 pm